These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 15942045

  • 1. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 2. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 3. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 4. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
    Xing Y, Ding J, Fan Q, Guan N.
    Exp Biol Med (Maywood); 2006 May 20; 231(5):585-93. PubMed ID: 16636307
    [Abstract] [Full Text] [Related]

  • 5. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Fukuda A, Fujimoto S, Iwatsubo S, Kawachi H, Kitamura K.
    Nephrology (Carlton); 2010 Apr 20; 15(3):321-6. PubMed ID: 20470301
    [Abstract] [Full Text] [Related]

  • 6. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 20; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 7. Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome.
    Ramadan R, Faour D, Awad H, Khateeb E, Cohen R, Yahia A, Torgovicky R, Cohen R, Lazari D, Kawachi H, Abassi Z.
    Nephrol Dial Transplant; 2012 Jun 20; 27(6):2231-41. PubMed ID: 22036940
    [Abstract] [Full Text] [Related]

  • 8. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N, Ding J, Deng J, Zhang J, Yang J.
    Pathol Int; 2004 Sep 20; 54(9):703-11. PubMed ID: 15363039
    [Abstract] [Full Text] [Related]

  • 9. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 20; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 10. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb 20; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 11. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 20; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 12. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB, Ye SF, Liang CL, Li YC, Yu YJ, Lai JM, Lin H, Zheng J, Zhou JY.
    J Ethnopharmacol; 2014 Feb 12; 151(3):1124-1132. PubMed ID: 24389029
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
    Takahashi A, Fukusumi Y, Yamazaki M, Kayaba M, Kitazawa Y, Tomita M, Kawachi H.
    J Nephrol; 2014 Dec 12; 27(6):627-34. PubMed ID: 25298195
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Dec 12; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 15. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy.
    Nakatsue T, Koike H, Han GD, Suzuki K, Miyauchi N, Yuan H, Salant DJ, Gejyo F, Shimizu F, Kawachi H.
    Kidney Int; 2005 Jun 12; 67(6):2239-53. PubMed ID: 15882266
    [Abstract] [Full Text] [Related]

  • 16. [Effects of Chinese herbal medicine Huaiqihuang Granule on nephrin and podocin expressions in renal tissues of rats with adriamycin-induced nephrosis].
    Sun W, Zhu Z, Yu J, Wang YH, Xiong M, Gao X, Zhao ZH, Liu XG.
    Zhong Xi Yi Jie He Xue Bao; 2011 May 12; 9(5):546-52. PubMed ID: 21565142
    [Abstract] [Full Text] [Related]

  • 17. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 May 12; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 18. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
    Wan YG, Sun W, Zhen YJ, Che XY, Pu HP, Wang Y, Li M, Ruan JG, Yan QJ.
    J Ethnopharmacol; 2011 Jun 22; 136(2):322-33. PubMed ID: 21570456
    [Abstract] [Full Text] [Related]

  • 19. Losartan and enalapril are comparable in reducing proteinuria in children.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, Santoro EP, Sisk CM, Lam C.
    Kidney Int; 2012 Oct 22; 82(7):819-26. PubMed ID: 22739977
    [Abstract] [Full Text] [Related]

  • 20. Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.
    Kawachi H, Suzuki K, Miyauchi N, Hashimoto T, Otaki Y, Shimizu F.
    Clin Exp Nephrol; 2009 Aug 22; 13(4):275-280. PubMed ID: 19266252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.